| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Asymchem Laboratories (Tianjin) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.20 |
| 52 Week High | CN¥3.20 |
| 52 Week Low | CN¥3.20 |
| Beta | 0.062 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ASLT.Y | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | 0.9% |
| 1Y | n/a | 21.5% | 32.4% |
Return vs Industry: Insufficient data to determine how ASLT.Y performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ASLT.Y performed against the US Market.
Price Volatility
| ASLT.Y volatility | |
|---|---|
| ASLT.Y Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ASLT.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ASLT.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 9,300 | Hao Hong | www.asymchem.com.cn |
Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services.
Asymchem Laboratories (Tianjin) Co., Ltd. Fundamentals Summary
| ASLT.Y fundamental statistics | |
|---|---|
| Market cap | US$3.75b |
| Earnings (TTM) | US$154.26m |
| Revenue (TTM) | US$841.66m |
25.0x
P/E Ratio4.6x
P/S RatioIs ASLT.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASLT.Y income statement (TTM) | |
|---|---|
| Revenue | CN¥5.90b |
| Cost of Revenue | CN¥3.23b |
| Gross Profit | CN¥2.67b |
| Other Expenses | CN¥1.59b |
| Earnings | CN¥1.08b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.05 |
| Gross Margin | 45.20% |
| Net Profit Margin | 18.33% |
| Debt/Equity Ratio | 0% |
How did ASLT.Y perform over the long term?
See historical performance and comparison